The latest closing stock price for Enlivex Therapeutics as of November 22, 2024 is 0.93.
An investor who bought $1,000 worth of Enlivex Therapeutics stock at the IPO in 2014 would have $-997 today, roughly -1 times their original investment - a -44.51% compound annual growth rate over 10 years.
The all-time high Enlivex Therapeutics stock closing price was 391.60 on August 27, 2014.
The Enlivex Therapeutics 52-week high stock price is 4.59, which is 393.5% above the current share price.
The Enlivex Therapeutics 52-week low stock price is 0.81, which is 12.9% below the current share price.
The average Enlivex Therapeutics stock price for the last 52 weeks is 1.98.
An investor who bought $1,000 worth of Enlivex Therapeutics stock at the IPO in 2014 would have $-997 today, roughly -1 times their original investment - a -44.51% compound annual growth rate over 10 years.
The all-time high Enlivex Therapeutics stock closing price was 391.60 on August 27, 2014.
The Enlivex Therapeutics 52-week high stock price is 4.59, which is 393.5% above the current share price.
The Enlivex Therapeutics 52-week low stock price is 0.81, which is 12.9% below the current share price.
The average Enlivex Therapeutics stock price for the last 52 weeks is 1.98.